Skip to site content

Indian Health Service The Federal Health Program for American Indians and Alaska Natives

NPTC
National Pharmacy & Therapeutics Committee

IHS National Core Formulary

The IHS National Core Formulary is not an inclusive formulary, but should be considered a baseline to build upon. These agents were reviewed clinically and were considered as standard of care medications for frequently encountered disease states within the Indian Health System. Agents listed on the IHS National Core Formulary should be available on your local formulary.

Special Notes:
- To search by keyword through this page for a specific drug product, press "Control F".
- * Items in RED in the table below, indicate a closed class item. Facilties should not have any other formulary items from these classes.
- ** Items in Gray have been removed from the NCF

Generic References/Guidelines AHFS
Classification
VA
Class
5-HT agonist (Triptan) any product 28:32.28 CN105
Acetaminophen   28:08.92 CN103
Albuterol (Proventil HFA®) Branded product 12:12.08 RE102
Albuterol nebulized solution   12:12.08 RE102
Alendronate Medication Guide [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov 92:24.00 HS900
Allopurinol   84:08.00 MS400
Anastrozole   10:00.00 AN500
Amitriptyline   28:14.04 CN601
Amlodipine   24:28.08 CV200
Angiotensin Receptor Blocker, ANY Removed April 2012; see Losartan 24:32.08 CV805
Aspirin   28:08.04.24 CN103
Atenolol   24:24.00 CV100
Atorvastatin calcium ONLY 40mg to 80mg doses (high intensity statin to lower ldl-c > 50%) 24:06.08 CV350
Atypical Antipsychotic any product 28.16 CN700
Buproprion Medication Guide [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov 28:16.04 AN200
Calcium any formulation 40:12 TN420
Carvedilol (immediate release formulation only)   24:04.00 CV100
Chlorthalidone     CV701
Clindamycin topical any product 84:04.04 DE752
Clonazepam Medication Guide [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov 28:16.04 CN400
Clopidogrel bisulfate Medication Guide [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov 20:12.18 BL117
Combination (70/30) insulin, Novolin Branded product 68:20.08 HS501
Combination insulin, Novolog (70/30) mix Branded product 68:20.08 HS501
Copper Intrauterine Device, (Paragard) Branded product; CFU for use by a skilled and priveleged provider 68.12 HS200
Corticosteroid topical (low potency) any product 84:06.00 DE200
Corticosteroid topical (Intermediate potency) any product 84:06.00 DE200
Dedicated Emergency Contraceptive Removed Sept 2013; any product 68.12 HS200
Depo-Medroxyprogesterone injection   68.32 HS800
Dextroamphetamine and Amphetamine (immediate release) Pediatric use only 28:20.04 CN801
Dextroamphetamine and Amphetamine (long-acting) Pediatric use only 28:20.04 CN801
Diclofenac any formulation 28:08.04.92 MS102
Digoxin   24:04.08 CV049
Diltiazem   24:28.92 CV200
Divalproex    28:12.92 CN400
Donepezil 5 mg and 10 mg strength 12:04 CN900
Doxazosin   24:20.00 CV150
Emtricitabine/Tenofovir (Truvada®) Post-Exposure Prophylaxis 08:18.08 AM800
Estradiol tablets   68.16.04 HS000
Ethambutol   08:16.04 AM500
Ethinyl estradiol/etonorgestrel vaginal ring (NuvaRing®)   68.12 GU400
Ethinyl estradiol/norelgestromin transdermal (Ortho-Evra®)   68.12 GU400
Etonogestril implant (Nexplanon®) Branded product; CFU for use by a skilled and priveleged provider 68.12 HS200
Fibric Acid Derivative any product 24:06.06 CV350
Finasteride   92:00.00 HS900
Fluoxetine   28:12.08 CN609
Fluticasone/Salmeterol (Advair®) Removed October 2012; Branded product
Medication Guide [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov
12:12.08.12 & 68.0 RE101/RE102
Furosemide   40:28.20 CV702
Gabapentin Medication Guide [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov 28:12.92 CN400
Gemfibrozil Removed February 2014; replaced with "Fibric Acid Derivative - any product" 240:6.06 CV350
Glipizide   68:20.20 HS502
Glucagon For outpatient use 68:22.12 HS503
Glyburide   68:20.20 HS502
H1 Antagonist-2nd generation, long-acting any product 04:00 AH000
Hydrochlorothiazide   40:28.20 CV701
Hydroxychloroquine   08:30.08  AP101
Ibuprofen   28:08.04.92 MS102
Imipramine Removed May 2014 28:14.04 CN601
Indomethacin   28:08.04.92 MS102
Intermediate-acting (NPH) insulin, Novolin Branded product 68:20.08 HS501
Intranasal corticosteroid (any) any product 52:08.08 NT200
Ipratropium MDI   12:08.08 RE105
Isoniazid   08:16.04 AM500
Isosorbide dinitrate Removed August 2013 24:12.08 CV250
Isosorbide mononitrate   24:12.08 CV250
Laxative, bulk forming any product 56:12 GA201
Laxative, stimulant any product 56:12 GA204
Laxative, osmotic any product 56:12 GA202
Letrozole   10:00.00 AN900
Levonorgestrel (Plan B One-Step®) Branded product 68.12 HS200
Levonorgestrel-releasing intrauterine device (Mirena®) Branded product; CFU for use by a skilled and priveleged provider 68.12 HS200
Levothyroxine   68:36.04 HS851
Lisinopril   24:32.04 CV800
Lithium   28:28.00 CN750
Long-acting insulin, Insulin Detemir (Levemir) Branded product 68:20.08 HS501
Lopinavir/Ritonavir (Kaletra®) Removed August 2013; Post-exposure prophylaxis;
Medication Guide [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov
08:18.08 AM800
Lorazepam   28:12.08 CN400
Losartan   24:32:08 CV805
Lovastatin Removed April 2012 24:06.08 CV350
Low-molecular weight heparin any product 20:12.04 BL110
Meloxicam   28:08.04.92 MS102
Metformin   68:20.04 HS502
Methotrexate   10:00.00 AN300
Methylphenidate (immediate release) Pediatric use only 28:20.92 CN802
Methylphenidate (long-acting) Pediatric use only 28:20.92 CN802
Metoprolol   24:24.00 CV100
Mometasone (Asmanex®) Branded product 68:04.00 RE101
Mometasone/Formoterol (Dulera®) Branded product 12:12.08.12 & 68.0 RE101/RE102
Monophasic Oral Contraceptive Pill  30-35mcg EE (medium) any product 68.12 HS200
Monophasic Oral Contraceptive Pill (OCP) 20mcg EE (low) any product 68:12 HS200
Montelukast   48:10.24 RE109
Naloxone   28:10 CN102
Naproxen   28:08.04.92 MS102
Niacin extended release (Niaspan®)   24:06.92 VT103
Nicotine Replacement Therapy any product 12:00 IM900
Nifedipine ( controlled or extended release)   24:28.08 CV200
Nitroglycerin 0.4 milligrams, sublingual   24:12.08 CV250
Nitroglycerin patch   24:12.08  CV250
Nortriptyline   26:16.04 CN601
Omeprazole (enteric coated) Removed February 2014; replaced with "Proton-Pump Inhibitors - any product", Closed class status removed July 2012 56:28.36 GA900
Ophthalmic Prostaglandin Analogue any product 52.36.00 OP109
Oxybutynin   86:12.00 GU201
Pioglitazone Removed February 2010
Medication Guide [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov
68:20.28 HS502
Pravastatin   24:06.08 CV350
Prazosin   24:20.00 CV150
Prednisone   68:04.00 HS051
Premarin® Vaginal Cream Branded product 68.16.04 HS000
Progestin (oral) any product 68.32 HS800
Progestin Only Oral Contraceptive Pill any product 68.32 HS800
Proton-Pump Inhibitor any product 56:28.36 GA900
Pyrazinamide   08:16.04 AM500
Raltegravir (Isentress®) Post-Exposure Prophylaxis 08:18.08.12 AM800
Ranitidine   56:28.12 GA301
Rapid-acting (regular) insulin, Novolin Branded product 68:20.08 HS501
Rifampin   08:16.04 AM500
Rifapentine   08:16.04 AM500
Rosuvastatin 20mg Removed April 2012 24:06.08 CV350
Salmeterol (Serevent®) Removed September 2011; Medication guide, communication plan [PDF] Exit Disclaimer: You Are Leaving www.ihs.gov 12:12.08 RE102
Salsalate   28:08.04.24 MS102
Sertraline   28:16.04 CN609
Sevelamer (Renvela®) For patients on dialysis that cannot use calcium based phosphate binders due to hypercalcemia; branded product 92:00.00 AD900
Simvastatin   24:06.08 CV350
Spironolactone   24:32.20 CV704
Sulfasalazine   08:12.20 GA900
Sulindac Removed May 2014 28:08.04 MS102
Tamoxifen   10:00.00 AN500
Tamsulosin   92:00.00 CV150
Terazosin Removed January 2012 24:20.00 CV150
Tetanus, Diptheria, and acellular Pertussis (Tdap)   80:08.00 IM100
Tiotropium (Spiriva®) Branded product 12:08.08 RE105
Topiramate   28:12.92 CN400
Trazodone   28:16.04 CN609
Tretinoin Topical any product 86:16.00 DE752
Triphasic Oral Contraceptive Pill (any) any product 68.12 HS200
Trospium   86:12.00 GU201
Ultra-rapid-acting insulin, Novolog Branded product 68:20.08 HS501
Vaccines all ACIP recommended vaccines for routine use in accordance with ACIP guidelines 80:12.00 IM100
Venlafaxine any formulation 28:16.04 CN609
Verapamil   24:28.92 CV200
Vitamin D any product 88.16 VT500
Warfarin   20:12.04 BL110
Back To Top
CPU: 81ms Clock: 0s